
The National Health Service in England has launched a vaccination campaign offering a free meningitis B vaccine to young people in response to an outbreak that occurred in Kent. The campaign aims to protect approximately one million eligible individuals through a two-dose vaccination program, with doses administered at least 28 days apart.
The vaccination program targets 17 and 18-year-olds in sixth form, as well as students under 25 entering residential university or college settings for the first time this autumn. Eligible groups include individuals born between 1 September 2007 and 31 August 2008, as well as those born on or after 21 July 2001 who are beginning higher education or residential further education programs. International students and those from other UK nations studying in England are also included. Nearly 90,000 doses have already been administered, with an additional 135,000 appointments scheduled for coming weeks.
Access to the vaccine is available through two pathways: 17 and 18-year-olds registered with a general practitioner can book through the NHS National Booking Service, while other eligible students can seek walk-in appointments at participating high street pharmacies across England without requiring GP registration. Young people born on or after 21 July 2001 can receive the vaccine on a walk-in basis if they meet residency requirements.
The meningitis B outbreak in Kent, which occurred earlier this year, resulted in 29 confirmed or suspected cases and two deaths and has been characterized as unprecedented in scale. Research indicates that first-year university students face approximately seven times higher risk than non-university peers of similar age due to increased social mixing and shared living arrangements. Meningitis B infection can cause serious complications including brain inflammation and sepsis, potentially resulting in disabilities such as hearing loss, amputations, and brain damage.
The MenB vaccine became part of the routine NHS childhood immunization program for babies born on or after 1 July 2015, meaning older teenagers and young adults previously missed this protection. Common side effects include mild fever, headache, and injection-site reactions that typically resolve within one to two days. Health officials emphasize that vaccination can prevent serious illness, though research indicates the vaccine does not necessarily prevent person-to-person transmission or provide long-term protection.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI